Longtime collaborators Phoenix Nuclear Labs and Shine Medical Technologies have entered into a supply and development agreement. Phoenix has agreed to provide neutron generators for use by Shine in its planned molybdenum-99 manufacturing facility. Shine will provide Phoenix support to improve its technology.
Technetium-99m prices are expected to rise in the coming years, according to Mallinckrodt. Rising molybdenum-99 production costs are to blame, including converting to use of low-enriched uranium, among other factors.
Shine Medical Technologies has signed a deal agreeing to supply GE Healthcare with the medical isotope molybdenum-99 once its manufacturing facility starts operation. A regulatory decision is pending for the Janesville, Wis., facility. It is expected to start operations by 2017.
Nordion is set to receive its first batch of molybdenum-99 isotopes from Russian firm Isotope. The shipment, of which Nordion is not specifying the amount, will "help alleviate the impact of the planned NRU reactor shutdown currently intended for mid-May 2011," Nordion said.
The U.S. Department of Energy's National Nuclear Security Administration has awarded NTP Radioisotopes, a unit of the Nuclear Energy Corporation of South Africa, a contract worth $25 million for the production of the medical isotope molybdenum-99 using low-enriched uranium. NTP Radioisotopes will be working with the Australian Nuclear Science and Technology Organisation in this initiative.